Igawa M - Search Results

1

Evaluation of the argyrophilic nucleolar organizer region, nuclear DNA content and mean nuclear area in transitional cell carcinoma of bladder using a quantitative image analyzer.

Shiina H, Urakami S, Shirakawa H, Shigeno K, Himeno Y, Mizutani M, Igawa M, Ishibe T. Shiina H, et al. Among authors: igawa m. Eur Urol. 1996;29(1):99-105. doi: 10.1159/000473726. Eur Urol. 1996. PMID: 8821699

2

Initial evaluation of prostate cancer with real-time elastography based on step-section pathologic analysis after radical prostatectomy: a preliminary study.

Sumura M, Shigeno K, Hyuga T, Yoneda T, Shiina H, Igawa M. Sumura M, et al. Among authors: igawa m. Int J Urol. 2007 Sep;14(9):811-6. doi: 10.1111/j.1442-2042.2007.01829.x. Int J Urol. 2007. PMID: 17760747

3

Simultaneous implantation of bilateral ureters into bladder acellular matrix graft after partial cystectomy in a porcine model.

Mitsui Y, Shiina H, Hiraoka T, Arichi N, Yasumoto H, Dahiya R, Tanagho EA, Igawa M. Mitsui Y, et al. Among authors: igawa m. BJU Int. 2012 Dec;110(11 Pt C):E1212-7. doi: 10.1111/j.1464-410X.2012.11553.x. Epub 2012 Oct 9. BJU Int. 2012. PMID: 23046198

4

Prediction of survival benefit using an automated bone scan index in patients with castration-resistant prostate cancer.

Mitsui Y, Shiina H, Yamamoto Y, Haramoto M, Arichi N, Yasumoto H, Kitagaki H, Igawa M. Mitsui Y, et al. Among authors: igawa m. BJU Int. 2012 Dec;110(11 Pt B):E628-34. doi: 10.1111/j.1464-410X.2012.11355.x. Epub 2012 Jul 12. BJU Int. 2012. PMID: 22788759

5

A case of primary retroperitoneal serous adenocarcinoma.

Arichi N, Yasumoto H, Mitsui Y, Hiraoka T, Honda S, Shiina H, Igawa M. Arichi N, et al. Among authors: igawa m. Int J Urol. 2011 Dec;18(12):844-6. doi: 10.1111/j.1442-2042.2011.02875.x. Epub 2011 Oct 12. Int J Urol. 2011. PMID: 21992013

6

Current chemotherapeutic strategies against bladder cancer.

Mitsui Y, Yasumoto H, Arichi N, Honda S, Shiina H, Igawa M. Mitsui Y, et al. Among authors: igawa m. Int Urol Nephrol. 2012 Apr;44(2):431-41. doi: 10.1007/s11255-011-0009-8. Epub 2011 Jun 12. Int Urol Nephrol. 2012. PMID: 21667254 Review.

7

Long-term control or possible cure? Treatment of stage D2 prostate cancer under chemotherapy using cisplatin and estramustine phosphate followed by maximal androgen blockade.

Urakami S, Shiina H, Sumura M, Honda S, Wake K, Hiraoka T, Inoue S, Ishikawa N, Igawa M. Urakami S, et al. Among authors: igawa m. Int Urol Nephrol. 2008;40(2):365-8. doi: 10.1007/s11255-007-9301-z. Int Urol Nephrol. 2008. PMID: 18092143

8

Usefulness of an immunochromatographical assay, PSA Rapid Test as a primary screening test for prostate cancer.

Shigeno K, Arichi N, Yoneda T, Kishi H, Shiina H, Igawa M. Shigeno K, et al. Among authors: igawa m. Int Urol Nephrol. 2006;38(3-4):565-9. doi: 10.1007/s11255-006-0086-2. Epub 2006 Nov 16. Int Urol Nephrol. 2006. PMID: 17111081

9

Expression of the survivin gene in prostate cancer: correlation with clinicopathological characteristics, proliferative activity and apoptosis.

Kishi H, Igawa M, Kikuno N, Yoshino T, Urakami S, Shiina H. Kishi H, et al. Among authors: igawa m. J Urol. 2004 May;171(5):1855-60. doi: 10.1097/01.ju.0000120317.88372.03. J Urol. 2004. PMID: 15076293

10

Bcl2 -938C/A polymorphism carries increased risk of biochemical recurrence after radical prostatectomy.

Hirata H, Hinoda Y, Kikuno N, Suehiro Y, Shahryari V, Ahmad AE, Tabatabai ZL, Igawa M, Dahiya R. Hirata H, et al. Among authors: igawa m. J Urol. 2009 Apr;181(4):1907-12. doi: 10.1016/j.juro.2008.11.093. Epub 2009 Feb 23. J Urol. 2009. PMID: 19237173

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results